DARE

0.43513.74%
SM

Sabrina Martucci Johnson

CEO, President, Principal Financial Officer, Secretary & Director

Ms. Sabrina Martucci Johnson serves as Director at BIOCOM, Inc. since February 2021 and serves as its Chairman since January 2025. Ms. Johnson Founded Dar? Bioscience since 2015 and serves as its Chief Executive Officer and President and is its Principal Financial Officer since January 2024. Ms. Johnson serves as a Director at Dar? Bioscience, Inc. since July 2017 and serves as its Secretary. She had been Independent Member of Supervisory Board at AtaiBeckley Inc. (formerly known as Atai Beckley N.V.) (formerly known as Atai Life Sciences N.V.) since 2021 and served as its Director until September 11, 2026. Ms. Johnson has extensive experience as a finance executive. Ms. Johnson serves as Secretary and Treasurer at Kyalin Biosciences, Inc. From July 2013 to October 2014, she served as the Chief Operating Officer and Chief Financial Officer at Womancare Global Trading. She served as the Chief Operating Officer and Acting Chief Financial Officer at H?Y? Bioscience International, LLC. She served as the Chief Financial Officer at Cypress Bioscience, Inc. since April 2002, Executive Vice President since February 2006, Chief Operating Officer since January 2008, also served as its Principal Accounting Officer. She served as an Interim Chief Financial Officer of Cypress Bioscience, Inc. from February 2002 to April 2002, Vice President of Marketing from March 2001 to April 2002, Chief Business Officer since February 2006, Vice President since April 2002 and also served as its Senior Vice President. She has been with Cypress Bioscience Inc. in August 1998 and held various positions from 1998 to 2000, including Product Director, Executive Director of Marketing and Sales and Vice President of Marketing and Sales and was responsible for mergers, acquisitions, divestitures, strategic Partnerships, capital raises, Investor Relations, commercial leadership, product launches and competitive analysis and market opportunity assessment and planning. She began her career in the Biotechnology industry in 1990 as a Research Scientist with Baxter Healthcare, Hyland Division. From 1993 to 1998, she held marketing and sales positions with Advanced Tissue Sciences, where she was responsible for global product positioning and development of promotional materials, strategic marketplace analysis reports and technical product support and spent a year in sales at Clonetics Corporation. She had been an Independent Director of Aethlon Medical, Inc. since January 4, 2018 until April 01, 2022. Ms. Johnson served as the Chief Financial Officer of the California Institute for Biomedical Research (now part of The Scripps Research Institute) from May 2015 to July 2017. She served as President of WomanCare Global Trading from October 2014 to May 2015. Ms. Johnson provided financial consulting services to the WomanCare Global family of companies, including the United Kingdom-based non-profit division, from November 2012 to July 2013. She served on the board of Planned Parenthood of the Pacific Southwest and Athena San Diego. She started her career in the biotechnology industry as a Research Scientist in 1990 with Baxter Healthcare, Hyland Division. She serves on the YWCA of San Diego County Board of Directors, Tulane University School of Science & Engineering Board of Advisors, University California San Diego Librarian?s Advisory Board and Project Concern International Audit Committee. She is an Entrepreneur-in-Residence of the CONNECT Springboard program for entrepreneurs and is a Member of Women Give San Diego, which funds non-profit organizations serving women and girls and Athena, which promotes professional growth for women executives. Ms. Johnson has an MIM from the American Graduate School of International Management (Thunderbird), a M Sc. in Biochemical Engineering from the University of London and a B Sc. in Biomedical Engineering from Tulane University.

Positions